Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine 5 mg versus 20 mg versus placebo crossover study in acquired cold urticaria
2005-006133-32Phase 4Completed
- Sponsor
- Allergie-Centrum Charité
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of desloratadine in Cold urticaria (CU) (3 arms), sponsored by Allergie-Centrum Charité. Primary endpoints: Efficacy of treatment and Reduction in development of urticaria lesions. Started Jun 2006; status: completed.
02
Drugs
desloratadine
03
Conditions
Cold urticaria (CU)
Beyond the preview
Go deeper on 2005-006133-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006133-32.